Jazz Pharmaceuticals Inc

Type: Company
Name: Jazz Pharmaceuticals Inc
First reported Aug 30 2014 - Updated Aug 30 2014 - 1 reports

Baidu, AerCap And Jazz Among Basing Top World Stocks

It was a mixed week for global markets, with stocks in the U.S. and Europe posting notable gains while the top indexes in China ceded ground.Stocks on IBD's Top 10 World Stocks list nearly all gained, some significantly, while others held beneath buy ... [Published Investor's Business Daily - Aug 30 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Jazz Pharmaceuticals (JAZZ) Showing Bullish Technicals With Resistance At $166.64

After closing Wednesday at $163.11, Jazz Pharmaceuticals Inc. (http://www.marketintelligencecenter.com/symbol/JAZZ"JAZZ) presents an attractive opportunity to get a 5.26% return in just 51 days, which is an annualized return of 37.62% (for comparison ... [Published Individual.com - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Gilead, Jazz Among 4 Top Big Cap Medicals To…

Jazz PharmaceuticalsBest-selling narcolepsy medication Xyrem made up two-thirds of Jazz's second-quarter sales. The company acquired Italian biotech Gentium earlier in the year.View Enlarged ImageJazz shares rose 1.7% to 163.56 on the stock market Tuesday, ... [Published Investor's Business Daily - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma

LONDON, August 27, 2014 /PRNewswire/ --On Tuesday, August 26, 2014, the NASDAQ Composite ended at 4,570.64, up 0.29%, the Dow Jones Industrial Average finished the day 0.17% higher at 17,106.70, and the S&P 500 closed at 2,000.02, up 0.11%. The gains ... [Published PR Newswire: Health - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 3 reports

Jazz Pharmaceuticals joins AstraZeneca and Lilly on Box's client list

Jazz Pharmaceuticals ($JAZZ) and Boston Scientific ( $BSX ) have begun using Box as their main platform for managing and collaborating on content. The companies join AstraZeneca ( $AZN ), Eli Lilly ( $LLY ) and Edwards Lifesciences on Box's list of life ... [Published Fierce Biotech IT - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Potential Jazz Pharmaceuticals (JAZZ) Trade Targets 4.78% Return

Jazz Pharmaceuticals Inc. (JAZZ) traded between $156.10 and $160.67 before closing at $158.83 Friday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s algorithms have picked a Oct. '14 $155.00 covered call for a ... [Published MarketIntelligenceCenter.com - Aug 25 2014]
First reported Aug 19 2014 - Updated Aug 20 2014 - 3 reports

Why Jazz Pharmaceuticals (JAZZ) Stock Is Gaining Today

NEW YORK (TheStreet) --aJazz Pharmaceuticals shares are up 0.92% to $153.92 on Tuesday afterahaving coverage initiated with an "overweight" rating and $190 price target by analysts at JPMorgan.The firm believes that the pharmaceutical company is well ... [Published The Street Latest - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 2 reports

JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

Shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) are up almost 20 percent over the past five trading sessions.JP Morgan started coverage of the company with an Overweight rating and $190 price target."In the context of an ongoing wave of consolidation in ... [Published Benzinga.com - Aug 19 2014]
First reported Aug 06 2014 - Updated Aug 07 2014 - 3 reports

Jazz Pharmaceuticals Acquires Worldwide Rights to VOD Treatment Defibrotide

08/06/14, Pharmaceutical Business Reviewbody: Ireland-based Jazz Pharmaceuticals has completed the acquisition of rights to defibrotide in the U.S. and all other countries in the Americas from Sigma-Tau Pharmaceuticals. In the European Union, defibrotide ... [Published AAPS Pharmceutica - Aug 07 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 3 reports

Jazz Pharmaceuticals Spikes In #PreMarket On Q2 Beat; Boosts Revenue Outlook

Jazz Pharmaceuticals (NASDAQ: JAZZ) shares spiked as much as three percent before retreating in pre-market trading Tuesday after the ...Related Stocks:JAZZ PHARMACEUTICAL NEWSTAR FINANCIALStock Market XML and JSON Data API provided by FinancialContent ... [Published Minyanville - Aug 06 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 4 reports

Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau..

Jazz Pharmaceuticals Plc - Ordinary Shares (MM) (NASDAQ:JAZZ)Intraday Stock ChartToday : Wednesday 6 August 2014DUBLIN , Aug. 5, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of rights to defibrotide ... [Published ADVFN India - Aug 05 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 2 reports

Jazz Pharmaceuticals (JAZZ) Showing Bearish Technicals

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with Jazz Pharmaceuticals Inc. (JAZZ) that should provide a 10.42% return in just 137 days. Sell one Dec. ... [Published MarketIntelligenceCenter.com - Aug 05 2014]

Quotes

"I've been involved with J L Turner since I was a first-year associate. They have always supported J L Turner. They have a long-standing commitment to J L Turner and various bar associations, as well. They encourage people to be involved in the community and civic responsibility. I don't think they ever took a position on the complaint" Price said of her bosses and Weil
After closing Wednesday at $163.11, Jazz Pharmaceuticals Inc. (http://www.marketintelligencecenter.com/symbol/JAZZ "JAZZ) presents an attractive opportunity to get a 5.26% return in just 51 days, which is an annualized return of 37.62% (for comparison purposes only). To enter this trade, sell one Oct. '14 $160.00 call for each 100 shares of JAZZ for a net debit of about $152.01. The net debit for this trade is also the break even point, which means this position has 6.81% downside protection."
...The companies join AstraZeneca AZN ), Eli Lilly LLY ) and Edwards Lifesciences on Box's list of life science clients. "Cloud technologies like Box have allowed us to remain nimble" AstraZeneca CIO David Smoley said in a statement. Release
...internal and external processes and increasing the speed and flow of information," said Whitney Bouck, general manager of enterprise at Box. "For companies like Jazz Pharmaceuticals and Boston Scientific, Box provides the platform that powers secure global collaboration and drives productivity company-wide."

More Content

All (300) | News (151) | Reports (0) | Blogs (135) | Audio/Video (0) | Fact Sheets (0) | Press Releases (13)
sort by: Date | Relevance
Winning Women: Mandy Price [Published Texas Lawyer - 16 hours ago]
Baidu, AerCap And Jazz Among Basing Top World S... [Published Investor's Business Daily - Aug 30 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 29 2014]
The RUC. "an Independent Group of Physicians?" ... [Published Health Care Renewal - Aug 28 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published Individual.com - Aug 28 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 28 2014]
Gilead, Jazz Among 4 Top Big Cap Medicals To… [Published Investor's Business Daily - Aug 27 2014]
Health Care Sector Stocks on our Radar -- Pacif... [Published PR Newswire: Health - Aug 27 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 27 2014]
Potential Jazz Pharmaceuticals (JAZZ) Trade Has... [Published MarketIntelligenceCenter.com - Aug 26 2014]
Cooley's Capital Markets Leadership Continues t... [Published Cooley - Aug 26 2014]
Jazz Pharmaceuticals Moves Up In Market Cap Ran... [Published Forbes.com - Aug 25 2014]
Jazz Pharmaceuticals Moves Up In Market Cap Ran... [Published Securities Technology Monitor - Aug 25 2014]
ETFs for Hedge Funds’ Favorite Pharma Stocks [Published Yahoo! Finance - Aug 25 2014]
Jazz Pharmaceuticals joins AstraZeneca and Lill... [Published Fierce Biotech IT - Aug 25 2014]
OpportunityAnalyzer: Graft-Versus-Host Disease ... [Published PredictWallStreet - Aug 25 2014]
Box Powers Cloud Collaboration for Leading Life... [Published Fierce Biotech IT - Aug 25 2014]
Potential Jazz Pharmaceuticals (JAZZ) Trade Tar... [Published MarketIntelligenceCenter.com - Aug 25 2014]
Jazz Pharmaceuticals and Boston Scientific Sele... [Published Individual.com - Aug 25 2014]
Pharma and Life Sciences Enterprises Mobilize w... [Published Mobile Enterprise - Aug 22 2014]
Stock Investors Bid Up Shares of Jazz Pharmaceu... [Published Individual.com - Aug 22 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 22 2014]
GVHD Market (Graft-Versus-Host Disease) Growing... [Published EMAILWIRE.com - Aug 22 2014]
Autohome, Qihoo Among Leaders Still Working On ... [Published Town Hall - Aug 22 2014]
Pharma ETF Investing 101 [Published Yahoo! Finance - Aug 21 2014]
BOSTON SCIENTIFIC : Box Powers Cloud Collaborat... [Published 4 Traders - Aug 21 2014]
Arch Biopartners appoints Haigh to board [Published Stockwatch - Aug 21 2014]
Arch Biopartners Appoints Adrian Haigh to Board... [Published Scottrade - Aug 21 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 21 2014]
Boston Scientific to deploy Box through AT [Published Business Cloud News - Aug 21 2014]
1 2 3 4 5 6 7 8 9 10
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 29 2014]
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Jazz Pharmaceuticals Inc. (JAZZ) today after it closed at $162.71 on Thursday. For more conservative investors, ...
The RUC. "an Independent Group of Physicians?" ... [Published Health Care Renewal - Aug 28 2014]
Introduction We just discussed how a major story in Politico has once again drawn attention to the opaque RUC (Resource Based Relative Value System Update Committee) and its important role in determining what physicians are paid for different ...
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 28 2014]
After closing Wednesday at $163.11, Jazz Pharmaceuticals Inc. (JAZZ) presents an attractive opportunity to get a 5.26% return in just 51 days, which is an annualized return of 37.62% (for comparison purposes only). To enter this trade, sell one Oct. '14 ...
Health Care Sector Stocks on our Radar -- Pacif... [Published PR Newswire: Health - Aug 27 2014]
LONDON, August 27, 2014 /PRNewswire/ --On Tuesday, August 26, 2014, the NASDAQ Composite ended at 4,570.64, up 0.29%, the Dow Jones Industrial Average finished the day 0.17% higher at 17,106.70, and the S&P 500 closed at 2,000.02, up 0.11%. The gains ...
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 27 2014]
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with Jazz Pharmaceuticals Inc. (JAZZ) that should provide a 4.88% return in just 52 days. Sell one Oct. '14 ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Jazz Pharmaceuticals Announces Pricing of $500 ... [Published Financial Services - Aug 08 2014]
The Zacks Analyst Blog Highlights: Medtronic, C... [Published Financial Services - Aug 01 2014]
Financial Results, Clinical Trial Initiations, ... [Published Financial Services - Jul 30 2014]
Biotech Companies Release Quarterly Financials ... [Published Financial Services - Jul 29 2014]
The Zacks Analyst Blog Highlights:Regado Biosci... [Published Financial Services - Jul 10 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.